VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd. has announced the resignation of director Robert Hodgkinson, effective July 22, 2024, who will continue to advise the company in a different capacity. The company, known for its AI-powered echocardiography products, is set to appoint a new director as part of its commitment to good governance and board renewal.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
